156 related articles for article (PubMed ID: 36568373)
1. Pan-cancer and single-cell analysis reveals
Yu H; Chen Q; Wang Z; Qian X; Pan Y
Front Genet; 2022; 13():1009325. PubMed ID: 36568373
[No Abstract] [Full Text] [Related]
2. Systematic analysis of the oncogenic role of FAM83D across cancers based on data mining.
Geng Y; Liu J; Wang Z; Liu T; Peng X; Huang Y
Cell Cycle; 2023 Apr; 22(8):1005-1019. PubMed ID: 36710419
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of FAM83D gene expression across human cancer types.
Walian PJ; Hang B; Mao JH
Oncotarget; 2016 Jan; 7(3):3332-40. PubMed ID: 26678035
[TBL] [Abstract][Full Text] [Related]
4.
Nie J; Lu L; Du C; Gao X
Transl Cancer Res; 2022 Oct; 11(10):3790-3802. PubMed ID: 36388033
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer.
Jin Y; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Jun; 20(1):172. PubMed ID: 35650627
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle.
Shi R; Sun J; Sun Q; Zhang Q; Xia W; Dong G; Wang A; Jiang F; Xu L
Am J Cancer Res; 2016; 6(11):2587-2598. PubMed ID: 27904773
[TBL] [Abstract][Full Text] [Related]
7. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
Yan L; Yao J; Qiu J
Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
[TBL] [Abstract][Full Text] [Related]
8. miRNA-142-3p functions as a potential tumor suppressor directly targeting FAM83D in the development of ovarian cancer.
Gao G; Guo X; Gu W; Lu Y; Chen Z
Aging (Albany NY); 2022 Apr; 14(8):3387-3399. PubMed ID: 35489022
[TBL] [Abstract][Full Text] [Related]
9. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer Analysis Identifies AIMP2 as a Potential Biomarker for Breast Cancer.
Qiu J; Zhou T; Wang D; Hong W; Qian D; Meng X; Liu X
Curr Genomics; 2023 Dec; 24(5):307-329. PubMed ID: 38235352
[TBL] [Abstract][Full Text] [Related]
11. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of family with sequence similarity 83 member D expression enhances cell proliferation and motility via activation of Wnt/β-catenin signaling and predicts poor prognosis in gastric cancer.
Wang F; Zhang S; Wei Y; Chen H; Jiao Z; Li Y
Cancer Manag Res; 2019; 11():6775-6791. PubMed ID: 31413630
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of FAM83D Enhances Radiosensitivity in Coordination with Irradiation by Inhibiting EMT via the Akt/GSK-3β/Snail Signaling Pathway in Human Esophageal Cancer Cells.
Yang XX; Ma M; Sang MX; Zhang XY; Zou NY; Zhu SC
Onco Targets Ther; 2020; 13():4665-4678. PubMed ID: 32547096
[TBL] [Abstract][Full Text] [Related]
14. PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer.
Zhao R; Chen S; Cui W; Xie C; Zhang A; Yang L; Dong H
Front Immunol; 2023; 14():1232047. PubMed ID: 37936713
[TBL] [Abstract][Full Text] [Related]
15. Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer.
Wang Y; Li Y; Jing Y; Yang Y; Wang H; Ismtula D; Guo C
Sci Rep; 2024 Apr; 14(1):8201. PubMed ID: 38589634
[TBL] [Abstract][Full Text] [Related]
16. FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7.
Wang Z; Liu Y; Zhang P; Zhang W; Wang W; Curr K; Wei G; Mao JH
Oncotarget; 2013 Dec; 4(12):2476-86. PubMed ID: 24344117
[TBL] [Abstract][Full Text] [Related]
17. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
18. Suppression of FAM83D Inhibits Glioma Proliferation, Invasion and Migration by Regulating the AKT/mTOR Signaling Pathway.
Li X; Sun C; Chen J; Ma JF; Pan YH
Transl Oncol; 2022 Aug; 22():101454. PubMed ID: 35617811
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
[TBL] [Abstract][Full Text] [Related]
20. FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma.
Liu X; Gao H; Zhang J; Xue D
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
